| Basics |
Haemonetics Corporation
Haemonetics Corp is a health care company. It provides products enabling in the processing, handling and analysis of blood and portfolio of integrated devices and information management tools to improve clinical outcomes.
|
| IPO Date: |
January 3, 1994 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$3.27B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.75 | 1.20%
|
| Avg Daily Range (30 D): |
$0.68 | 1.07%
|
| Avg Daily Range (90 D): |
$0.93 | 1.45%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.3M |
| Avg Daily Volume (30 D): |
.39M |
| Avg Daily Volume (90 D): |
.68M |
| Trade Size |
| Avg Trade Size (Sh.): |
85 |
| Avg Trade Size (Sh.) (30 D): |
40 |
| Avg Trade Size (Sh.) (90 D): |
49 |
| Institutional Trades |
| Total Inst.Trades: |
8,637 |
| Avg Inst. Trade: |
$2.68M |
| Avg Inst. Trade (30 D): |
$3.62M |
| Avg Inst. Trade (90 D): |
$3.49M |
| Avg Inst. Trade Volume: |
.04M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.71M |
| Avg Closing Trade (30 D): |
$5.87M |
| Avg Closing Trade (90 D): |
$8.05M |
| Avg Closing Volume: |
51.83K |
|
|
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$3.33
|
|
$3.33
|
|
Diluted EPS
|
$3.31
|
|
$3.31
|
|
Revenue
|
$ 1.36B
|
$
|
$ 1.36B
|
|
Gross Profit
|
$ 748.96M
|
$
|
$ 748.96M
|
|
Net Income / Loss
|
$ 167.68M
|
$
|
$ 167.68M
|
|
Operating Income / Loss
|
$ 221.82M
|
$
|
$ 221.82M
|
|
Cost of Revenue
|
$ 611.87M
|
$
|
$ 611.87M
|
|
Net Cash Flow
|
$ 127.96M
|
$
|
$ 127.96M
|
|
PE Ratio
|
20.78
|
|
|
|
